Impact of elexacaftor/tezacaftor/ivacaftor on biomarkers of cystic fibrosis hepatobiliary involvement in the PUSH study
J Pediatr Gastroenterol Nutr. 2025 Nov 26. doi: 10.1002/jpn3.70290. Online ahead of print. ABSTRACT OBJECTIVES: The impact of elexacaftor/tezacaftor/ivacaftor (ETI) on cystic fibrosis (CF) hepatobiliary …